A. Kazimi | executive |
Todd Anthony | executive |
John Hamm | executive |
Good afternoon, and welcome to the Cumberland Pharmaceuticals Second Quarter 2024 Financial Report and Company Update. This call is being recorded at the company's request and will be archived on its website for 1 year from today's date. I would now like to turn the call over to Molly Aggas, Account Supervisor at the Dalton Agency, who handles Cumberland Communications. Molly, please go ahead.
Hello, everyone.